Is There an Oral GLP-1? Yes — Here's What Is Actually Approved
Short answer
Yes. In December 2025 the FDA approved once-daily oral semaglutide 25 mg, sold under the Wegovy brand, for chronic weight management — the first oral GLP-1 approved for obesity rather than diabetes. A separate, lower-dose oral semaglutide has been approved for type 2 diabetes since 2019.
That is a different product from the compounded oral GLP-1s sold by some telehealth providers. Those are not FDA-approved, and the distinction matters more than the price difference.
This is not medical advice. Tirzeptides is an independent comparison site, not a healthcare provider. Nothing here creates a doctor-patient relationship or replaces a conversation with a licensed clinician. GLP-1 medications are prescription drugs with real risks and contraindications. Talk to a qualified provider before starting, stopping or changing any treatment.
What is approved, and for what
There are two separate things people mean by "oral GLP-1", and conflating them is where most of the confusion starts.
Oral semaglutide 25 mg (Wegovy). Approved by the FDA in December 2025 for chronic weight management in adults. This is the first GLP-1 pill approved for obesity. Approval was supported by OASIS 4, a 64-week phase 3 trial in which participants taking the 25 mg daily tablet lost a mean of 13.6% of body weight, against 2.2% for placebo.1
Lower-dose oral semaglutide (Rybelsus, 7 mg and 14 mg). Approved since 2019, but for type 2 diabetes, not for weight loss. Weight loss on these doses is real but considerably smaller, and prescribing it purely for weight management is off-label. During 2026 Novo Nordisk moved these strengths onto the Ozempic brand name in the US, so the Rybelsus name is being phased out — if you see conflicting information about what "Rybelsus" is, that renaming is usually why.2
How the pill compares with the injection
The honest summary is that the approved pill works, but not quite as well as the highest-performing injections.
- Oral semaglutide 25 mg — about 13.6% mean weight reduction over 64 weeks in OASIS 4.
- Injected semaglutide — about 13.7% over 72 weeks in the SURMOUNT-5 head-to-head trial.
- Injected tirzepatide — about 20.2% over the same 72 weeks in that trial.
These come from different trials with different populations and durations, so they are not a clean like-for-like comparison. The broad picture they support is that oral and injected semaglutide land in a similar range, and tirzepatide is meaningfully ahead of both.
The pill also carries real practical constraints. Oral semaglutide has to be taken on an empty stomach with no more than about half a glass of plain water, and you wait at least 30 minutes before eating, drinking or taking other medication. People who cannot keep to that reliably tend to get less out of it.
Bodybuilding Health+
Clearest pricing ladder · scored 8.0/10
Save $480 a year on a 12-month plan
- Clear tiered pricing published for every bundle length
- Microdosing protocols available for people who want lower doses
- Wide catalogue: NAD+ and sermorelin from $129/mo, PT-141, glutathione, GHK-Cu
Compounded oral GLP-1s are a different product
Several telehealth providers advertise oral GLP-1 drops, tablets or troches at prices well below the approved pill. These are compounded preparations. Compounded drugs are not reviewed or approved by the FDA for safety, effectiveness or manufacturing quality, and the oral bioavailability of semaglutide is genuinely difficult to achieve — the approved tablet relies on a specific absorption enhancer to get the molecule across the stomach lining at all.
That is the substantive concern with compounded oral versions specifically: an injection largely bypasses the absorption problem, whereas an oral formulation has to solve it. A compounded oral product that does not solve it may simply deliver less drug than the label implies.
None of that makes compounded oral GLP-1 useless, and some people choose it deliberately because they will not inject. It does mean the comparison to the approved pill is not like-for-like, and you should not assume the trial results above transfer to it.
Which providers on this site offer an oral option
Of the eight providers we compare, one offers a compounded oral option: SkinnyRx. It is not LegitScript certified, and it sells compounded rather than FDA-approved oral medication.
If your priority is an FDA-approved oral GLP-1 specifically, that is a prescription for oral semaglutide 25 mg through a normal prescriber and pharmacy, not a compounded telehealth plan. Pallas Health is the only partner here that also facilitates brand-name cash-pay prescriptions.
The short version
An FDA-approved oral GLP-1 for weight loss now exists, which was not true a year ago. It works about as well as injected semaglutide and less well than injected tirzepatide, it has fiddly dosing rules, and it is not the same thing as the cheaper compounded oral products sold online. Decide which of those two you are actually being offered before comparing prices.
Sources
- Oral Semaglutide Wins Cardiovascular Approval, Followed by First-Ever Weight Management Indication — MedCentral
- From Rybelsus to the Ozempic Pill: What Pharmacists Need to Know About the Next Generation of Oral Semaglutide — Pharmacy Times
- Semaglutide — StatPearls — NIH National Library of Medicine
Our top three, compared
Ranked by the six published weights on how we rank. All three are paid partners.
Related questions
- Which GLP-1 is best for weight loss?
- Which GLP-1 is best for cardiovascular benefit?
- What does GLP-1 do in the body?
- How long do GLP-1 side effects last?
- How fast does GLP-1 weight loss happen?
All GLP-1 questions answered → · GLP-1 price index → · Compare the 8 providers →